The short version
- Peres Jepchirchir faces provisional suspension after testing positive for erythropoietin, a banned blood-boosting substance.
- The sample was collected in Kenya before her dominant win at the 2026 Sydney Marathon.
- This case adds to a growing list of suspensions involving Kenyan athletes and raises questions about national anti-doping protocols ahead of the 2029 World Championships.
The Athletics Integrity Unit has provisionally suspended Peres Jepchirchir, the reigning Olympic and world marathon champion, following a positive test for a prohibited substance. The announcement marks a significant disruption in the career of the 33-year-old Kenyan athlete, who had recently secured a decisive victory at the Sydney Marathon. The suspension is immediate but temporary, pending a full investigation into the circumstances surrounding the adverse analytical finding.
The sample that triggered this action was collected during an out-of-competition test while Jepchirchir was in Kenya. This timing is notable because it preceded her performance in Sydney on August 30, 2026, where she finished with a time of two hours, 18 minutes, and 31 seconds. She won the race by a margin of three minutes and 40 seconds, finishing well ahead of her compatriot Irene Chepet Cheptai. The positive result specifically identified erythropoietin, commonly known as EPO.
EPO is a hormone naturally produced by the kidneys that stimulates the production of red blood cells. When administered artificially, it increases the oxygen-carrying capacity of the blood, which can enhance endurance performance. However, synthetic EPO is strictly banned in athletics because it provides an unfair physiological advantage. The substance is difficult to detect, as it remains in the body for only a short window after administration, making out-of-competition testing a critical component of anti-doping efforts.
Jepchirchir’s career has been defined by consistent excellence on the global stage. She captured gold at the Tokyo Olympics in 2021 and returned to Japan to win the World Championships in September 2025. Her resume includes victories in four of the six World Marathon Majors: New York in 2021, Boston in 2022, London in 2024, and Sydney in 2026. Additionally, she holds the world record for the half-marathon, a title she secured in 2017 and defended multiple times in 2020.
The suspension places Jepchirchir among a large group of Kenyan athletes who have faced disciplinary action in recent years. Since 2017, the Athletics Integrity Unit has suspended or banned more than 140 Kenyan competitors for doping violations. This list includes prominent figures such as Ruth Chepngetich, the current women’s marathon world record holder. The frequency of these cases has drawn international attention to the integrity of athletic programs within Kenya.
The timing of this development coincides with increased pressure on Kenyan sports authorities to strengthen their anti-doping frameworks. World Athletics recently awarded Nairobi the right to host the 2029 World Championships, a decision that is expected to heighten scrutiny of the nation’s compliance with global standards. Stakeholders are likely to view this case as a test of how effectively local and international bodies can collaborate to ensure fair competition.
While the provisional suspension prevents Jepchirchir from competing in sanctioned events, it does not constitute a final determination of guilt. The investigation will examine whether the substance entered her system intentionally or inadvertently. If the findings support a violation, she could face a lengthy ban and potential disqualification of recent results. Conversely, if mitigating factors are identified, the outcome may be less severe.
For now, the focus remains on the procedural steps required to resolve the case. The Athletics Integrity Unit must complete its review before any further sanctions are imposed. Until then, Jepchirchir’s status remains in limbo, and her recent achievements are subject to potential retroactive adjustment depending on the final verdict. The athletic community awaits clarity on how this case will be resolved and what it means for the future of marathon racing.
This incident underscores the ongoing challenges in detecting performance-enhancing drugs, particularly those with short detection windows like EPO. It also highlights the vulnerability of high-profile athletes to scrutiny when testing protocols are rigorous. As the investigation proceeds, all parties involved must adhere to established guidelines to ensure a fair and transparent process.
The broader implications extend beyond Jepchirchir’s individual career. The case may influence how anti-doping agencies allocate resources for out-of-competition testing in regions with high volumes of elite athletes. It also serves as a reminder that even the most decorated competitors are not immune to the risks associated with modern pharmacological interventions in sports.
Sources behind this briefing
Go to the original reporting
- The Guardian US↗World and Olympic marathon champion Jepchirchir suspended after positive doping test
- BBC News↗World champion Jepchirchir fails drugs test
